07:00 , Oct 24, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine/metabolic disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Metabolic disease G protein-coupled receptor 171 (GPR171) Cell culture and mouse studies suggest modulating GPR171 activity could help treat metabolic...